Bupivacaine/Meloxicam | m-entrepreneurship.com

Product Name :
Bupivacaine/Meloxicam

Search keywords :
Meloxicam

drugId :
null

Target Vo:
Sodium channel alpha subunit

Target Vo Short Name :
SCNA

Moa_Name:
Cyclooxygenase-2 inhibitors

First Approval Country :
EU

First Approval Date Filter:
2020

Origin Company_Name :
Heron Therapeutics

Active Company_Name :
Heron Therapeutics

Active Indication_Name:
Pain, Postoperative

In Active Indication_Name:
Bunion

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Myosin light chain kinase Rabbit mAb site
Anti-Mouse TCR gamma/delta Antibody (UC7-13D5) custom synthesis
Phospho-eIF2A (Ser51) Antibody: Phospho-eIF2A (Ser51) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-eIF2A (Ser51). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts